New research indicates that people who come off popular GLP-1 drugs like Mounjaro or Wegovy tend to recover lost weight far faster than those who halt traditional diet and exercise regimens.
Published data in a prominent health publication shows that while obese individuals can lose substantial amounts of their body weight while using the jabs, the weight returns at an average rate of nearly a kilo each month upon discontinuation.
"Users purchasing such drugs must be aware of the potential of fast weight regain when the therapy ends," stated expert Dr. Susan Jebb.
That rate of recovery implies a reversion to starting weight within about a year and a half.
Weighing Treatments
The analysis, which examined dozens of trials involving over 9,000 of patients, compared the results of the injectable medications with other pills.
The team point out that people who shed pounds through lifestyle changes alone generally experience a slower weight regain—around 100 grams monthly—post-intervention.
Explaining the Fast Rebound
Experts propose the mechanism of the jabs accounts for the heightened regain.
GLP-1 drugs mimic a natural hormone called GLP-1, which moderates hunger.
"Artificially providing the hormone concentrations several times higher than the body's typical production may cause the system to produce less of its endogenous hormone, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics specialist.
"Stopping of this medication results in hunger is unsuppressed, making excessive eating much more probable."
An Ongoing Condition?
The NHS recommend the injections for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Professionals say that, due to the high risk of relapse, the treatment should be considered ongoing.
This view is reinforced by pharmaceutical companies, who state that the results "emphasize the chronic nature of obesity," akin to managing conditions like hypertension.
Patient Accounts
Individuals who have stopped the medication explain a sudden resurgence of cravings.
"It felt as if a switch that goes on and you become ravenous," described an individual.
This difficulty is exacerbated if patients have not adopted sustainable dietary or behavioural changes during therapy.
Significant Use
Recent estimates indicate that a significant number of people in the UK have tried weight-loss jabs in the past year, with interest continuing to grow.
- Use is greater among females compared to men.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion access the drugs through private prescriptions rather than public health services.
Finally, researchers stress that while these medications are effective agents for shedding pounds, they are not a standalone fix and lasting health benefits hinges on integrated lifestyle support.